A. T. Akpınar, "Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography," NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4, pp.405, 2006
Akpınar, A. T. 2006. Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography. NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4 , 405.
Akpınar, A. T., (2006). Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography. NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4, 405.
Akpınar, ALİ. "Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography," NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4, 405, 2006
Akpınar, ALİ T. . "Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography." NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4, pp.405, 2006
Akpınar, A. T. (2006) . "Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography." NUCLEAR MEDICINE COMMUNICATIONS , vol.27, no.4, p.405.
@article{article, author={ALİ TAYYAR AKPINAR}, title={Early clinical experience and impact of [F-18]fluorodeoxyglucose positron emission tomography}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2006, pages={405} }